LOSS OF LYMPHOCYTE CHALONE ACTIVITY IN MICE WITH AUTO-IMMUNE DISEASE

被引:6
作者
ATTALLAH, AM
STEINBERG, AD
AHMED, A
SELL, KW
机构
[1] USN,MED RES INST,DEPT IMMUNOL,BETHESDA,MD 20014
[2] NIAMDD,ARTHRITIS & RHEUMAT BRANCH,BETHESDA,MD 20014
来源
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY | 1979年 / 59卷 / 02期
关键词
D O I
10.1159/000232257
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Lymphocyte chalone from the spleens of old BALB/c, young BALB/c and young NZB mice caused significant suppression of the proliferative response of BALB/c and NZB spleen cells to T and B mitogens, whereas lymphocyte chalone from old NZB spleen did not suppress. Lymphocyte chalone from young and old NZB mice was tested using different ages of NZB/NZW responding spleen cells; at all ages concanavalin A- and lipopolysaccharide-induced proliferation was suppressed less by the chalone from old NZB mice than from that of young NZB mice. The responding NZB/NZW cells were suppressed equivalently at all ages studied. The basis for the loss of lymphocyte chalone activity in old NZB mice remains unknown; however, it appears likely that this event has a role in the disturbance of the negative feedback control system which contributes to NZB autoimmune disease.
引用
收藏
页码:186 / 191
页数:6
相关论文
共 13 条
[1]   SPECIFIC AND ENDOGENOUS MITOTIC INHIBITOR OF LYMPHOCYTES (CHALONE) [J].
ATTALLAH, AM ;
SUNSHINE, GH ;
HUNT, CV ;
HOUCK, JC .
EXPERIMENTAL CELL RESEARCH, 1975, 93 (02) :283-292
[2]  
ATTALLAH AM, 1976, CHALONES, P141
[3]  
EVANS MARGARET M., 1968, CLIN EXP IMMUNOL, V3, P375
[4]  
GARCIAGIRALT E, 1972, J IMMUNOL, V109, P878
[5]  
GAZDAR AF, 1971, CLIN EXP IMMUNOL, V8, P501
[6]  
Houck J. C., 1976, CHALONES
[7]   IMMUNOSUPPRESSIVE PROPERTIES OF LYMPHOCYTE CHALONE [J].
HOUCK, JC ;
ATTALLAH, AM ;
LILLY, JR .
NATURE, 1973, 245 (5421) :148-150
[8]  
KLASSEN LW, 1977, J IMMUNOL, V119, P830
[9]   INCREASED SURVIVAL OF NZB-W MICE GIVEN MULTIPLE SYNGENEIC YOUNG THYMUS GRAFTS [J].
KYSELA, S ;
STEINBERG, AD .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1973, 2 (01) :133-137
[10]  
STOBO JD, 1972, J IMMUNOL, V109, P692